Latest Arctic Sun medical device Stories
Therapeutic Hypothermia equipment market has over 10 devices, yet Therapeutic Hypothermia remains underused.
Whole body cooling in comatose patients who have suffered a heart attack can limit the damage to brain tissue caused by the restoration of blood flow and oxygen.
Therapeutic hypothermia – cooling the body and brain down to 33°C – is the method used worldwide to treat cardiac arrest, even though a lower body temperature may raise the risk of side-effects.
The brain-preserving cooling treatment known as therapeutic hypothermia is rarely being used in patients who suffer cardiac arrest while in the hospital, despite its proven potential to improve survival and neurological function.
LOUISVILLE, Colo., May 25, 2011 /PRNewswire/ -- MedivanceÂ®, Inc. today announced that it had been named to the Mercury 100 ranking of fastest growing companies in the Boulder Valley as determined by the Boulder County Business Report.
Mayo Clinic researchers confirmed that patients who receive therapeutic hypothermia after resuscitation from cardiac arrest have favorable chances of surviving the event and recovering good functional status.
LOUISVILLE, Colo., Sept. 15 /PRNewswire/ -- Medivance today announced the introduction of its next-generation therapeutic temperature management device, the non-invasive Arctic SunÂ® 5000.
LOUISVILLE, Colo., May 25 /PRNewswire/ -- A day after delivering her fourth child at Anaheim Regional Medical Center in Anaheim, California last December, 34-year-old Brynn Ervin suffered a cardiac arrest, the result of massive blood clots lodged in the main arteries that take blood to her lungs.
LOUISVILLE, Colo., Jan.
LOUISVILLE, Colo., Sept. 9 /PRNewswire/ -- The number of Arctic Sun(R) users among hospitals ranked top 20 jumped to 90 percent this year from 72 percent last year, Medivance announced today.